Quest Diagnostics

R&D Trends

Cancer Research U.K. invests $23.6 million in new major centers

Friday, June 26, 2015 09:16 AM

Cancer Research U.K. has launched Major Centers in Oxford, Manchester and Cambridge, with each receiving $7.7 million to boost their work in personalized cancer medicine and early detection research.

More... »


PrimeGen Biotech opens new research facility, HQ in California

Wednesday, June 24, 2015 10:16 AM

PrimeGen Biotech, a privately-held research firm, has opened a new 10,000 square-foot research facility located in Santa Ana, Calif. Founded by co-founder of AST Computers and former CEO of SRS Labs, Thomas C.K. Yuen plans to utilize PrimeGen's new research facility and his experience in marketing technologies to lead PrimeGen's team of research scientists in the discovery of new breakthroughs in stem cell science, and bringing advanced treatments of degenerative and aging related diseases to market.

More... »


Juniper, OxSonics partner for cancer drug delivery platform

Wednesday, June 24, 2015 10:02 AM

Juniper Pharma Services, a contract development and manufacturing organization (CDMO) subsidiary of Juniper Pharmaceuticals, has entered into a long-term collaboration with OxSonics to support the development, scale-up and GMP manufacturing of OxSonics' proprietary "sono-sensitive particles." OxSonics was established in July 2013 to develop and commercialize therapeutic ultrasound advancements invented at the University of Oxford's Institute of Biomedical Engineering.

More... »

Zeiss, UC Berkeley support Brain Microscopy Innovation Center

Monday, June 22, 2015 11:56 AM

ZEISS is participating in a new public-private partnership with University of California Berkeley as part of the Brain Microscopy Innovation Center (BrainMIC), a component of the Berkeley BRAIN Initiative. The Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative was launched by President Obama in 2013 and is focused on revolutionizing understanding of the human brain, with the goal of helping researchers uncover the mysteries of such brain disorders as Alzheimer’s and Parkinson’s diseases, depression and traumatic brain injury. 

More... »

Teva, Microchips Biotech partner on digital drug delivery technology

Monday, June 22, 2015 11:01 AM

Teva Pharmaceutical Industries and Microchips Biotech, a Lexington, Mass.-based provider of microchip-based implants, have entered into a partnership to explore innovative ways to apply Microchips Biotech’s implantable drug delivery device to Teva’s portfolio of products with the goal of enhancing clinical outcomes for patients on chronic drug therapies.

More... »

Eli Lilly partners with Dana-Farber Cancer Institute, Sarah Cannon Research Institute

Monday, June 22, 2015 10:38 AM

Eli Lilly has inked two separate deals, one with the Dana-Farber Cancer Institute to research new medicines under development to fight cancer, and the second with the Sarah Cannon Research Institute (SCRI) to co-develop an investigational oncology compound, LY3023414, a PI3K/mTOR dual inhibitor.

More... »

AMRI, PerkinElmer collaborate on Buffalo Medical Hub

Friday, June 19, 2015 12:14 PM

Global CRO Albany Molecular Research (AMRI) and CRO PerkinElmer are collaborating in connection with the opening of AMRI's drug discovery center as part of the new Buffalo Medical Innovation and Commercialization Hub (BMIC). Co-located on the Buffalo Niagara Medical Campus and part of the larger commitment by the State of New York with SUNY Polytechnic Institute, the Hub will accelerate drug discovery and innovation, and ultimately support the creation of more than 250 high tech jobs.

More... »

AstraZeneca, Inserm collaborate on type 2 diabetes, chronic kidney disease

Friday, June 19, 2015 11:37 AM

AstraZeneca has announced a three-year research collaboration with the French National Institute of Health and Medical Research (Inserm) to investigate new therapeutic approaches to type 2 diabetes and chronic kidney disease (CKD). The aim of the collaboration is to advance understanding of the biological mechanisms that underpin these conditions and develop new treatments based on this knowledge.

More... »

Report: Pharma R&D pipeline value jumps 18% to $493 billion

Wednesday, June 17, 2015 10:32 AM

Emerging therapeutic categories and a string of breakthrough drug approvals are powering key drug sales across the U.S. and Europe, fueling a projected 5% increase in global prescription sales over the next five years, according to the EvaluatePharma World Preview 2015, Outlook to 2020 report from life science market intelligence firm Evaluate. With the FDA approving an unprecedented 50 drugs in 2014, eight of which are forecast to have sales of more than $1 billion five years after launch, sustained R&D productivity may finally be within reach.

More... »

MLSC, COBTH, UMass Med launch web portal to promote collaboration

Wednesday, June 17, 2015 09:38 AM

The Massachusetts Life Sciences Center (MLSC) partnered with the Conference of Boston Teaching Hospitals (COBTH) and the University of Massachusetts Memorial Medical Center to the launch the Massachusetts Clinical Innovation Gateway. The new web portal will allow life sciences companies from around the world to seek opportunities to partner with Massachusetts academic medical centers (AMCs) on research and clinical initiatives.

More... »

CWWeekly

June 29

FDA and PatientsLikeMe collaborate to test social media adverse event reporting

Boston-area teaching hospitals launch web portal to attract life science companies

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

June

TransCelerate Biopharma turns three
High-profile consortium has made inroads fixing wasteful practices, but it still has more work ahead

Pharma industry improves its tarnished reputation
Delivering innovation, social responsibility will help rebuild trust

Already a subscriber?
Log in to your digital subscription.

Purchase the June issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

May

Job satisfaction mixed as workload increases
Salaries not keeping pace with rise in work, responsibilities

Gamification moving from early science to patient use
Pharma looking to use games for early diagnosis, recruitment, adherence

Already a subscriber?
Log in to your digital subscription.

Purchase the May issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs